Skip to main content
. Author manuscript; available in PMC: 2019 Aug 1.
Published in final edited form as: Clin Genitourin Cancer. 2018 Feb 5;16(4):e761–e769. doi: 10.1016/j.clgc.2018.01.011

Figure 1.

Figure 1

Patient Selection in a Study of Cardiovascular Risk Among Survivors of Testicular Cancer

Abbreviations: BEP = bleomycin, etoposide, and cisplatin; CVD = cardiovascular disease; EP = etoposide and cisplatin; FRS = Framingham Risk Score; TCSs = testicular cancer survivors.